Furthermore, the EMA has withdrawn the weight loss medication rimonabant, a selective cannabinoid type 1 receptor antagonist, due to its reported links to increased risks of depression and suicide [70]
That's only if you pay for a year's supply in advance
Michael DeShields, MD, the clinical adviser of the Discovery Institute in New Jersey, says access to Wegovy has improved over time, but insurance companies like Aetna still cover it inconsistently
Kawalec P, Mikrut A, opuch S (2014) The safety of dipeptidyl peptidase-4 (DPP-4) inhibitors or sodium-glucose cotransporter 2 (SGLT-2) inhibitors added to metformin background therapy in patients with type 2 diabetes mellitus: a systematic review and meta-analysis
However, due to the slimming properties of the drug, semaglutide is often abused by non-diabetics, non-obese individuals, and young people